Anti-Human CD140a Recombinant Antibody(Olaratumab)

Name: Anti-Human CD140a Recombinant Antibody(Olaratumab)
Brand: KMD Bioscience
SKU: YR1233

YR1233

科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab

DATASHEET MSDS

Product Description

Alias	科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab
Catalog Number	YR1233
Molecular Name	Olaratumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses").
CAS Number	1024603-93-7
Application	IF, IP, Neut, FuncS, ELISA, FCM
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	154 kDa
Target	CD140a[Homo sapiens]

Login